Balanced news tone
News Sentiment
6826 sentiment intelligence
Shanghai Haohai Biological Technology Co., Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
66/100 classification confidence.
directly relevant articles
high-authority source matches
+1.2% over one week, -2.1% over four weeks, trend inactive, and below fair value.
Eirion Therapeutics, Inc. Closes $40 Million Series A Investment and Licensing Deal with Shanghai Haohai Biological Technology Ltd.
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Eirion Therapeutics, Inc. Closes $40 Million Series A Investment and Licensing Deal with Shanghai Haohai Biological Technology Ltd.
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 09 Mar 2021 08:00
- Source
- PR Newswire
Heyu Biological Technology (HYBT) Stock Price, News & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Sep 2020 07:39
- Source
- MarketBeat
Is Shanghai Haohai Biological Technology Co Ltd’s (HKG:6826) CEO Paid Enough Relative To Peers?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Nov 2018 08:00
- Source
- Market source